Clinically Relevant Anatomy[edit | edit source]
Wallerian degeneration is an active process of retrograde degeneration of the distal end of an axon that is a result of a nerve lesion. It occurs between 7 to 21 days after the lesion occurs. After the 21st day, acute nerve degeneration will show on the electromyograph.
Within a nerve, each axon is surrounded by a layer of connective tissue called the endoneurium. The axons are bundled together into groups called fascicles, and each fascicle is wrapped in a layer of connective tissue called the perineurium. Finally, the entire nerve is wrapped in a layer of connective tissue called the epineurium.
Mechanism of Injury[edit | edit source]
The pathological process of Wallerian degeneration is in 3 stages;
Within approximately 30 minutes of injury, there is a separation of the proximal and distal ends of the nerve. After a short latency period, the transected membranes are sealed until degeneration which is marked by the formation of axonal sprouts. This occurs in less than a day and allows for nerve renervation and regeneration
This occurs by the 7th day when macrophages are signaled by the Schwann cells to clean up axonal and myelin debris. Usually, the rate of clearance is slower in the Central Nervous System(CNS) than in the Peripheral Nervous System (PNS) due to the clearance rate of myelin. Another reason for the different rates is the change in permeability of the blood-tissue barrier in the two systems. In PNS, the permeability increases throughout the distal stump, but the barrier disruption in CNS is limited to just the site of injury. Also in the CNS, oligodendrocytes inhibit regeneration.
If soma/ cell body is damaged, a neuron cannot regenerate. However, if the injury is at the end of the axon, at a growth of 1mm per day, the distal segment undergoes granular disintegration over several days to weeks and cytoplasmic elements begin to accumulate.
Clinical Presentation[edit | edit source]
Presentations of nerve damage may include:
- Reduced or loss of function in associated structures to damaged nerves
- Gradual onset of numbness, prickling or tingling in feet or hands, which can spread upward into legs and arms
- Sharp, jabbing, throbbing, freezing, or burning pain
- Extreme sensitivity to touch
- Lack of coordination and falling
- Muscle weakness or paralysis if motor nerves are affected
- Neuromatous or causalgia pain
Diagnostic Procedures[edit | edit source]
- Nerve conduction studies
- Sensation deficit and skin condition tests
- Muscle strength/loss
- Functional deficits
Outcome Measures[edit | edit source]
Depends on various criteria including pain and psychosocial skills but could include:
Management / Interventions[edit | edit source]
References[edit | edit source]
- Purves D, Augustine GJ, Fitzpatrick D, Hall WC, LaMantia AS, McNamara JO, White LE.Neuroscience (4 ed.). Sinauer Associates. 2008 pp. 11–20.
- Gaudet AD, Popovich PG &Ramer MS. Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury.Journal of Neuroinflammation.2011 Available from.https://jneuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-8-110 (accessed on 06/04/2021)
- Coleman MP, Conforti L, Buckmaster EA, Tarlton A, Ewing RM, Brown MC, Lyon MF, Perry VH (August 1998). "An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse". Proceedings of the National Academy of Sciences of the United States of America. 95 (17): 9985–90. Bibcode:1998PNAS...95.9985C. doi:10.1073/pnas.95.17.9985. PMC 21448. PMID 9707587.
- Medical & Exercise Physiology School.Wallerian degeneration/ regeneration process of nerve fiber/axon cut and progressive response. Available from https://www.youtube.com/watch?v=kbzYML05Vac (last accessed 5 March 2021)
- The Young Orthopod. Nerve Regeneration. Available from https://www.https://www.youtube.com/watch?v=P02ea4jf50g&t=192s (last accessed 6 March 2021)
- Hsu M,and Stevenson FF.Wallerian Degeneration and Recovery of Motor Nerves after Multiple Focused Cold Therapies. US National Library of Medicine.National Institutes of Health.2015 ; 51(2): 268–275.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315870/ (accessed on 6/04/2021)